Table 1.
Characteristics of patients.
| All patients (n = 60) |
WLI-NBI (n = 30) |
WLI-TXI (n = 30) |
p value | |
|---|---|---|---|---|
| Age (years ± SD) | 72.7 ± 7.7 | 73.0 ± 7.6 | 72.3 ± 7.8 | .726 |
| Sex [male, n (%)] | 34 (56.7%) | 16 (53.3%) | 18 (60.0%) | .602 |
| Height (cm ± SD) | 160.5 ± 16.2 | 161.5 ± 9.7 | 159.4 ± 20.9 | .618 |
| Body weight (kg ± SD) | 59.8 ± 11.0 | 59.6 ± 11.7 | 59.9 ± 10.4 | .917 |
| H. pylori infection, Negative/Current/Eradicated [n/n/n] | 7/1/52 | 3/1/26 | 4/0/26 | .565 |
| Smoking, Never/Current/Past [n/n/n] | 39/1/20 | 19/0/11 | 20/1/9 | .532 |
| Alcohol [n (%)] | 38 (63.3%) | 19 (63.3%) | 19 (63.3%) | 1.000 |
| Diseases | ||||
| Peptic ulcer [n (%)] | 5 (8.3%) | 3 (10.0%) | 2 (6.7%) | .640 |
| Gastric cancer [n (%)] | 3 (5.0%) | 2 (6.7%) | 1 (3.3%) | .544 |
| Cancer (others) [n (%)] | 15 (25.0%) | 5 (16.7%) | 10 (33.3%) | .136 |
| Hyperlipidaemia [n (%)] | 22 (36.7%) | 15 (50.0%) | 7 (23.3%) | .032 |
| Hypertension [n (%)] | 30 (50.0%) | 19 (63.3%) | 11 (36.7%) | .039 |
| Diabetes mellites [n (%)] | 11 (18.3%) | 7 (23.3%) | 4 (13.3%) | .317 |
| Drugs | ||||
| PPI [n (%)] | 18 (30.0%) | 9 (30.0%) | 9 (30.0%) | 1.000 |
| NSAID [n (%)] | 0 (0%) | 0 (0%) | 0 (0%) | |
| Antiplatelet drug [n (%)] | 17 (28.3%) | 8 (26.7%) | 9 (30.0%) | .774 |
| Anticoagulant [n (%)] | 5 (8.3%) | 3 (10.0%) | 2 (6.7%) | .640 |
| Bisphosphonate | 2 (3.3%) | 0 (0%) | 2 (6.7%) | .150 |
| F-scale questionnaire | ||||
| Acid-related symptom score | 2.5 ± 3.4 | 2.1 ± 2.7 | 2.9 ± 4.0 | .349 |
| Dysmotility-related symptom score | 2.2 ± 2.7 | 1.6 ± 2.2 | 2.7 ± 3.1 | .120 |
| F-scale total score | 4.6 ± 5.8 | 3.7 ± 4.8 | 5.6 ± 6.7 | .196 |
Abbreviations: H. pylori: Helicobacter pylori; NBI: narrow-band imaging; SD: standard deviation; TXI: texture and colour enhancement imaging; WLI: white-light imaging.